Zyprexa hurt Lilly revenue growth in '05

Zyprexa hurt Lilly revenue growth in '05 | IndyStar.com: "Struggling to replace eroding sales from its No. 1 drug Zyprexa, Eli Lilly and Co. managed to post revenue growth of just 6 percent last year, its smallest increase since 2002." [IndyStar.com]